期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Cumulative sum analysis score and phacoemulsification competency learning curve 被引量:3
1
作者 Gustavo Vedana Filipe G.Cardoso +5 位作者 Alexandre S.Marcon Licio E.K.Araújo Matheus Zanon Daniella C.Birriel guilherme watte Albert S.Jun 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2017年第7期1088-1093,共6页
AIM: To use the cumulative sum analysis score(CUSUM) to construct objectively the learning curve of phacoemulsification competency.METHODS: Three second-year residents and an experienced consultant were monitored ... AIM: To use the cumulative sum analysis score(CUSUM) to construct objectively the learning curve of phacoemulsification competency.METHODS: Three second-year residents and an experienced consultant were monitored for a series of 70 phacoemulsification cases each and had their series analysed by CUSUM regarding posterior capsule rupture(PCR) and best-corrected visual acuity. The acceptable rate for PCR was 〈5%(lower limit h) and the unacceptable rate was 〉10%(upper limit h). The acceptable rate for bestcorrected visual acuity worse than 20/40 was 〈10%(lower limit h) and the unacceptable rate was 〉20%(upper limit h). The area between lower limit h and upper limit h is called the decision interval. RESULTS: There was no statistically significant difference in the mean age, sex or cataract grades between groups. The first trainee achieved PCR CUSUM competency at his 22 nd case. His best-corrected visual acuity CUSUM was in the decision interval from his third case and stayed there until the end, never reaching competency. The second trainee achieved PCR CUSUM competency at his 39^ th case. He could reach best-corrected visual acuity CUSUM competency at his 22 ^nd case. The third trainee achieved PCR CUSUM competency at his 41 st case. He reached bestcorrected visual acuity CUSUM competency at his 14 ^th case.CONCLUSION: The learning curve of competency in phacoemulsification is constructed by CUSUM and in average took 38 cases for each trainee to achieve it. 展开更多
关键词 phacoemulsification learning curve cumulative sum analysis score posterior capsule rupture best corrected visual acuity cataract surgery
下载PDF
Feasibility of endoscopic papillary large balloon dilation to remove difficult stones in patients with nondilated distal bile ducts
2
作者 Julio Carlos Pereira Lima Giusepe Saifert Moresco +5 位作者 Ivan David Arciniegas Sanmartin Isabela Contin guilherme Pereira-Lima guilherme watte Stephan Altmayer Carlos Eduardo Oliveira dos Santos 《World Journal of Gastrointestinal Endoscopy》 2022年第7期424-433,共10页
BACKGROUND Current guidelines recommend not performing papillary large balloon dilation in patients with nondilated distal bile ducts.AIM To assess the feasibility of balloon dilation to remove difficult stones in pat... BACKGROUND Current guidelines recommend not performing papillary large balloon dilation in patients with nondilated distal bile ducts.AIM To assess the feasibility of balloon dilation to remove difficult stones in patients with nondilated distal bile ducts.METHODS Data from 1289 endoscopic retrograde cholangiopancreatography(ERCP)procedures were obtained from two prospective studies.While 258 cases had difficult stones(>1 cm,multiple>8,impacted,or having a thin distal duct),191 underwent biliary dilation up to 15 mm after endoscopic sphincterotomy.Cholangiographies of these cases were retrospectively reviewed in order to classify the distal bile duct and both the stone size and number.Primary outcomes were clearance rate at first ERCP and complications.RESULTS Of the 191 patients(122 women and 69 men;mean age:60 years)who underwent biliary dilation for difficult stones,113(59%)had a nondilated or tapered distal duct.Patients with a dilated distal duct were older than those with nondilated distal ducts(mean 68 and 52 years of age,respectively;P<0.05),had more stones(median 4 and 2 stones per patient,respectively;P<0.05),and had less need for additional mechanical lithotripsy(6.4%vs 25%,respectively;P<0.05).Clearance rate at first ERCP was comparable between patients with a dilated(73/78;94%)and nondilated distal ducts(103/113;91%).Procedures were faster in patients with a dilated distal duct(mean 17 vs 24 min,respectively;P<0.005).Complications were similar in both groups(6.4%vs 7.1%,respectively).CONCLUSION Large balloon dilation for difficult stones is feasible in patients with a nondilated or even tapered distal duct. 展开更多
关键词 Difficult bile duct stones Endoscopic retrograde cholangiopancreatography Balloon dilation Complications Biliary dilation CHOLANGIOGRAPHY
下载PDF
The Loss of Heterozygosity of FHIT Gene in Sporadic Breast Cancer
3
作者 Lisiane Silveira Zavalhia Andrea Pires Souto Damin +5 位作者 Grasiela Agnes Aline Weber Taís Frederes Kramer Alcalde Laura Marinho Dorneles guilherme watte Adriana Vial Roehe 《Journal of Oncology Research》 2021年第2期33-39,共7页
function.FHIT is a potential tumor suppressor gene.Although the precise FHIT molecular mechanism of action is not well understood,evidences suggest that Fhit protein reduced levels are involved in mammary carcinogenes... function.FHIT is a potential tumor suppressor gene.Although the precise FHIT molecular mechanism of action is not well understood,evidences suggest that Fhit protein reduced levels are involved in mammary carcinogenesis.The aim of this study was to investigate if FHIT LOH could influence on sporadic breast cancer(BC)biological behavior,through its association with prognostic factors for sporadic BC.Tumor tissue and peripheral blood samples were analyzed using the microsatellite marker D3S1300.The findings were associated with clinicopathological parameters including overall survival.LOH was detected in 31.1%(52/167)of the informative BC’cases.Considering clinical and pathological characteristics we have found no significant association with FHIT LOH status.The mean follow-up time was 80 months.After the Cox regression analysis two parameters remained associated with BC’s risk of death:TNM stage III and IV-HR=3.74(95%CI,1.16-12.1)P=0.027 and disease relapse HR=3.14(CI 95%1.26-7.80)P=0.014.This study shows that FHIT LOH by itself is not a prognostic factor for sporadic BC.Further researches are required to elucidate the functional role of FHIT LOH concerning to BC. 展开更多
关键词 Breast cancer D3S1300 LOH SURVIVAL Loss of heterozygosity
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部